Development of an Optimal Antibiotic Regime for Long-term Therapy in Stable Chronic Obstructive Pulmonary Disease (COPD)

NCT01398072 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD).

Interventions

DRUG: Moxifloxacin
DRUG: Azithromycin
DRUG: Doxycycline
DRUG: Placebo

Sponsor

University College, London

Collaborators

[object Object]
[object Object]
[object Object]